A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plateA new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate

TheWell Bioscience Launches VitroPrime™ 3D Culture and Imaging Plate for Organoid and 3D Cell Culture Workflows

2026/02/09 22:02
3 min read

A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate

MONMOUTH JUNCTION, N.J., Feb. 9, 2026 /PRNewswire/ — TheWell Bioscience today announced the launch of the VitroPrime™ 3D Culture and Imaging Plate, a next-generation 3D cell culture plate engineered to support organoid and advanced 3D cell culture workflows with minimal physical disturbance. The VitroPrime™ 3D Culture and Imaging Plate enables long-term culture, fixation, immunofluorescence staining, and high-resolution imaging to be performed entirely in-plate—eliminating sample transfer while preserving fragile hydrogel-based 3D structures.

Through a unique combination of sample-locking architecture, passive media exchange, and imaging-grade optics, the VitroPrime™ 3D Culture and Imaging Plate addresses persistent challenges in 3D cell culture, including hydrogel floating, sample rotation, and sample loss during routine handling. By minimizing manual manipulation and vessel-to-vessel transfers, the plate improves reproducibility, supports longitudinal studies, and enables consistent data generation across experiments.

Most current 3D cell culture systems, including organoid models, rely on culture vessels originally designed for 2D monolayer cultures rather than delicate, hydrogel-based 3D constructs. As a result, routine media exchange and downstream processing frequently disrupt 3D architecture and spatial organization. In addition, fixation, staining, and imaging often require transferring samples between vessels, increasing the risk of structural damage, sample loss, and experimental variability—an especially costly challenge for organoid workflows, where samples are often rare, time-intensive to generate, and difficult to replace. These limitations make reliable long-term culture, high-resolution imaging, and laboratory automation difficult to achieve within a single 3D cell culture plate.

The VitroPrime™ 3D Culture and Imaging Plate was engineered to overcome these challenges by enabling a true end-to-end 3D workflow—from sample seeding and long-term culture to downstream processing and imaging—within a single vessel, with zero sample transfer and minimal physical disturbance.

“For years, we’ve spoken with researchers around the world who struggle to find the right culture vessel for 3D organoid workflows—one that can prevent hydrogel floating, allow live-cell tracking, enable easy media exchange and sample fixation without sample loss, and support high-resolution imaging,” said John Huang, CEO of TheWell Bioscience. “It took several years of rational design and iterative development to translate these unmet needs into a practical, scalable solution.”

At the core of the VitroPrime™ plate is a dedicated lateral media-exchange channel that enables passive, disturbance-free diffusion of nutrients, stains, and fixatives while preserving the integrity of delicate 3D constructs. An integrated anti-floating and anti-rotation design ensures stable positioning during longitudinal monitoring, organoid development studies, live-cell imaging, and high-content analysis. The plate also features an ultra-clear, premium cover-glass bottom optimized for high-resolution and confocal imaging.

The VitroPrime™ 3D Culture and Imaging Plate integrates seamlessly with TheWell Bioscience’s end-to-end, xeno-free 3D cell culture platform, including VitroGel® hydrogels, RocketCell™ media, CytoGrow™ growth factors, and Cyto3D® downstream analysis reagents. Together, the platform delivers a defined, scalable, and automation-ready workflow for more relevant and reproducible advanced 3D cell culture models.

VitroPrime™ 3D Culture and Imaging Plate is currently available in 6-, 12- and 96-well formats. For more information, please visit www.thewellbio.com

About TheWell Bioscience Inc.
TheWell Bioscience delivers a comprehensive, end-to-end, xeno-free platform for robust and reproducible 3D cell models. Its integrated ecosystem of xeno-free hydrogels, media, cultureware, and downstream reagents eliminate animal-derived variability, support scalable applications in precision medicine, cell therapy, and biomanufacturing, and advances New Approach Methodologies (NAMs) through more human-relevant in vitro models.

Contact:
Kyra Baricaua
9738554955
408834@email4pr.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thewell-bioscience-launches-vitroprime-3d-culture-and-imaging-plate-for-organoid-and-3d-cell-culture-workflows-302681692.html

SOURCE TheWell Bioscience Inc.

Market Opportunity
Cellframe Logo
Cellframe Price(CELL)
$0.0672
$0.0672$0.0672
+1.05%
USD
Cellframe (CELL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

What Does Market Cap Really Mean in Crypto — and Why Australians Care

What Does Market Cap Really Mean in Crypto — and Why Australians Care

Introduction: What Does Market Cap Mean in Cryptocurrency Ridgewell Tradebit is an automated cryptocurrency trading platform that helps users better understand
Share
Techbullion2026/02/09 23:34
Taiko Makes Chainlink Data Streams Its Official Oracle

Taiko Makes Chainlink Data Streams Its Official Oracle

The post Taiko Makes Chainlink Data Streams Its Official Oracle appeared on BitcoinEthereumNews.com. Key Notes Taiko has officially integrated Chainlink Data Streams for its Layer 2 network. The integration provides developers with high-speed market data to build advanced DeFi applications. The move aims to improve security and attract institutional adoption by using Chainlink’s established infrastructure. Taiko, an Ethereum-based ETH $4 514 24h volatility: 0.4% Market cap: $545.57 B Vol. 24h: $28.23 B Layer 2 rollup, has announced the integration of Chainlink LINK $23.26 24h volatility: 1.7% Market cap: $15.75 B Vol. 24h: $787.15 M Data Streams. The development comes as the underlying Ethereum network continues to see significant on-chain activity, including large sales from ETH whales. The partnership establishes Chainlink as the official oracle infrastructure for the network. It is designed to provide developers on the Taiko platform with reliable and high-speed market data, essential for building a wide range of decentralized finance (DeFi) applications, from complex derivatives platforms to more niche projects involving unique token governance models. According to the project’s official announcement on Sept. 17, the integration enables the creation of more advanced on-chain products that require high-quality, tamper-proof data to function securely. Taiko operates as a “based rollup,” which means it leverages Ethereum validators for transaction sequencing for strong decentralization. Boosting DeFi and Institutional Interest Oracles are fundamental services in the blockchain industry. They act as secure bridges that feed external, off-chain information to on-chain smart contracts. DeFi protocols, in particular, rely on oracles for accurate, real-time price feeds. Taiko leadership stated that using Chainlink’s infrastructure aligns with its goals. The team hopes the partnership will help attract institutional crypto investment and support the development of real-world applications, a goal that aligns with Chainlink’s broader mission to bring global data on-chain. Integrating real-world economic information is part of a broader industry trend. Just last week, Chainlink partnered with the Sei…
Share
BitcoinEthereumNews2025/09/18 03:34
MicroStrategy Bought Another 1.142 BTC: Total 714K BTC

MicroStrategy Bought Another 1.142 BTC: Total 714K BTC

The post MicroStrategy Bought Another 1.142 BTC: Total 714K BTC appeared on BitcoinEthereumNews.com. MicroStrategy Continues BTC Purchases MicroStrategy, the world
Share
BitcoinEthereumNews2026/02/09 23:06